期刊
JOURNAL OF CONTROLLED RELEASE
卷 357, 期 -, 页码 620-629出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2023.04.013
关键词
Neutrophil extracellular traps; Targeted delivery; Genetic engineering; Liver metastases; Premetastatic niche
Neutrophil extracellular traps (NETs) are web-like chromatin structures coated with granule proteins that can trap microorganisms. However, they can also cause damage to host tissue and contribute to the development of various diseases. Researchers developed biomimetic CCDC25-overexpressing cell membrane hybrid liposomes that specifically target NETs and efficiently eliminate them, providing a promising therapeutic approach for NET-associated diseases.
Neutrophil extracellular traps (NETs) are web-like chromatin structures that are coated with granule proteins and trap microorganisms. However, NETs can damage the host tissue, contribute to the development of autoimmunity and lead to other dysfunctional outcomes in noninfectious diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), diabetes, atherosclerosis, vasculitis, thrombosis, and cancer. As a potential therapeutic approach, targeted ablation of neutrophil extracellular traps is of utmost importance for the treatment of NET-associated diseases. Here, the specific interaction between CCDC25 and NETs was exploited to produce biomimetic CCDC25-overexpressing cell membrane hybrid liposomes capable of targeting NETs in NETassociated diseases. The hybrid liposomes were constructed by fusing cell membrane nanovesicles derived from genetically engineered cells, which stably express CCDC25, and the resulting cell membrane hybrid liposomes exhibited enhanced affinity for NETs in two different NET-associated disease models. Furthermore, after encapsulation of DNase I in the liposomes, the nanoformulation efficiently eliminated NETs and significantly suppressed the recruitment of neutrophils. Overall, we present a bionic nanocarrier that specifically targets NETs in vivo and successfully inhibits colorectal cancer liver metastases; importantly, this could be a promising therapeutic approach for the treatment of NET-associated diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据